Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03500991
Title HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications

central nervous system cancer

Therapies

HER2 CAR-T cells

Age Groups: child
Covered Countries USA


No variant requirements are available.